STERIS plc reported earnings results for the third quarter and nine months ended December 31, 2024. For the third quarter, the company reported sales was USD 1,370.57 million compared to USD 1,297.72 million a year ago. Net income was USD 173.53 million compared to USD 140.74 million a year ago. Basic earnings per share from continuing operations was USD 1.76 compared to USD 1.5 a year ago. Diluted earnings per share from continuing operations was USD 1.75 compared to USD 1.49 a year ago. Basic earnings per share was USD 1.76 compared to USD 1.42 a year ago. Diluted earnings per share was USD 1.75 compared to USD 1.42 a year ago. For the nine months, sales was USD 3,978.98 million compared to USD 3,719.31 million a year ago. Net income was USD 468.97 million compared to USD 379.62 million a year ago. Basic earnings per share from continuing operations was USD 4.7 compared to USD 4.03 a year ago. Diluted earnings per share from continuing operations was USD 4.68 compared to USD 4.01 a year ago. Basic earnings per share was USD 4.75 compared to USD 3.84 a year ago. Diluted earnings per share was USD 4.73 compared to USD 3.82 a year ago.
STERIS is an Ohio-based manufacturer and supplier of infection prevention, microbial reduction, and other procedural surgical products for the healthcare sector.